Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.
Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.
复制标题
DOI:
10.1021/acs.jmedchem.7b00112
复制
发表时间:
2017-04-13
影响因子:
7.3
通讯作者:
Larsen SD
中科院分区:
文献类型:
--
作者:
Waldschmidt HV;Homan KT;Cato MC;Cruz-Rodríguez O;Cannavo A;Wilson MW;Song J;Cheung JY;Koch WJ;Tesmer JJ;Larsen SD
In heart failure, the β-adrenergic receptors (βARs) become desensitized and uncoupled from heterotrimeric G proteins. This process is initiated by G protein-coupled receptor kinases (GRKs), some of which are upregulated in the failing heart making them desirable therapeutic targets. The serotonin reuptake inhibitor paroxetine was previously identified as a GRK2 inhibitor. Utilizing a structure based drug design approach we modified paroxetine to generate a small compound library. Included in this series is a highly potent and selective GRK2 inhibitor, 14as, with an IC50 of 30 nM against GRK2 and greater than 230-fold selectivity over other GRKs and kinases. Furthermore, 14as showed a 100-fold improvement in cardiomyocyte contractility assays over paroxetine and a plasma concentration higher than its IC50 for over seven hours. Three of these inhibitors, including 14as, were additionally crystallized in complex with GRK2 to give insights into the structural determinants of potency and selectivity of these inhibitors.
登录
查看更多内容
DOI:
10.2741/3898
发表时间:
2011-06-01
期刊:
Frontiers in bioscience (Landmark edition)
影响因子:
--
作者:
Huang ZM;Gold JI;Koch WJ
通讯作者:
Koch WJ
影响因子:
9.3
作者:
Hullmann J;Traynham CJ;Coleman RC;Koch WJ
通讯作者:
Koch WJ
影响因子:
4.8
作者:
Homan, Kristoff T.;Waldschmidt, Helen V.;Tesmer, John J. G.
通讯作者:
Tesmer, John J. G.
影响因子:
4.8
作者:
Komolov, Konstantin E.;Bhardwaj, Anshul;Benovic, Jeffrey L.
通讯作者:
Benovic, Jeffrey L.
影响因子:
17.1
作者:
Schumacher SM;Gao E;Zhu W;Chen X;Chuprun JK;Feldman AM;Tesmer JJ;Koch WJ
通讯作者:
Koch WJ